Small Cap
Drug Manufacturers - General
Stocks Ranked by
Market Capitalization
| Name | Market cap | Price |
Price change % |
|
|---|---|---|---|---|
|
AMRN
1
Amarin Corp
AMRN
$293M
| $293M | $13.87 | 0.22% |
|
2
Lineage Cell Therapeutics
LCTX
$260M
| $260M | $1.03 | 3.74% |
|
Small Cap Drug Manufacturers - General Stocks at a Glance
Large drug manufacturers sell diversified portfolios of branded medicines backed by deep development pipelines. Patent lives set the clock: blockbuster franchises fund the R&D and acquisitions needed to outrun expirations, supporting durable margins and dividends.
There are 2 small cap Drug Manufacturers - General stocks — companies in the Drug Manufacturers - General industry with a market cap between $250M and $2B — worth a combined $553M.
The largest by market cap are Amarin Corp (AMRN) at $293M and Lineage Cell Therapeutics (LCTX) at $260M.
Among institutional investors, Amarin Corp (AMRN) drew the most net new fund positions in Q2 2026: 19 funds opened new positions, taking total fund holders up 11 (16%) quarter-over-quarter.
- Combined market cap: $553M across 2 stocks.
- Small Cap: market cap between $250M and $2B.
- Largest constituent: Amarin Corp (AMRN), $293M market cap.
- Most net new fund positions in Q2 2026: Amarin Corp (AMRN), +11 holders.
Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.